Practical Strategies: Managing Daily Life with bvFTD
At a Glance
Managing behavioral variant frontotemporal dementia (bvFTD) requires adapting the environment rather than curing symptoms. Key strategies include using off-label medications for behavioral issues, engaging in occupational therapy like the Tailored Activity Program, and establishing early legal protections.
Living with behavioral variant frontotemporal dementia (bvFTD) requires a shift from trying to “fix” the symptoms to managing the environment. Because the disease often strikes younger people and preserves physical strength, the day-to-day challenges are distinct from those seen in other forms of dementia [1]. There is currently no cure or FDA-approved medication specifically for bvFTD, but there are strategies to manage symptoms and protect your family’s well-being [2].
Managing Symptoms with Medication
While no drug stops the disease, some medications are used “off-label” to help control the most distressing behaviors [2].
- SSRIs (Antidepressants): Selective Serotonin Reuptake Inhibitors, such as citalopram or sertraline, are often the first line of defense to reduce impulsivity, irritability, and obsessive-compulsive behaviors [3][4]. Important Note: These medications typically take 4-6 weeks to reach full efficacy, so patience is required.
- Trazodone: Frequently used at night to help with sleep disturbances and irritability [4].
- Atypical Antipsychotics (Use with Extreme Caution): In severe cases of aggression, low doses of atypical antipsychotics may be used. FDA Black Box Warning: All antipsychotics carry a black box warning for an increased risk of mortality in elderly patients with dementia-related psychosis. In FTD, patients are also highly sensitive to side effects that cause severe stiffness and movement issues [5]. These should only be considered as a last resort when the patient is a danger to themselves or others.
The Tailored Activity Program (TAP)
Non-drug interventions are often more effective than medication for managing bvFTD symptoms [6]. One evidence-based approach is the Tailored Activity Program (TAP) [7].
In this program, an occupational therapist works with the family to:
- Assess Capabilities: Identify remaining strengths (e.g., folding laundry or enjoying rhythmic music) [6].
- Create Custom Activities: Design 2-3 specific activities that match those strengths to keep the patient engaged and reduce “problem” behaviors like pacing or repetitive questioning [7].
- Simplify the Environment: Remove “triggers”—for example, if the patient overeats, keep food out of sight, or if they obsessively check the mail, use a lock on the mailbox [6][8].
Practical Safety and Legal Steps
Because people with bvFTD often lose their “social compass” and financial judgment before they lose their memory, it is critical to act early. If the patient still has capacity, these steps should be taken collaboratively [9][10].
- Secure Finances: Consult an Elder Law attorney or specialized financial planner. Because bvFTD often strikes primary breadwinners, the financial toxicity of the disease requires professional legal structuring. Move funds to secure accounts and monitor credit cards for impulsive purchases [10].
- Address Driving: Anosognosia means the patient will likely believe they are a perfect driver. Driving with a formal dementia diagnosis carries severe legal, financial, and insurance liability risks. Check your local state or national laws regarding mandatory DMV reporting for dementia. A formal driving evaluation may be necessary to remove liability from the family [11].
- Legal Protections: Ensure you have a Durable Power of Attorney for both healthcare and finances completed early on [12].
The Weight of Caregiving
Research consistently shows that caregivers of people with bvFTD face higher levels of psychological distress than those caring for people with Alzheimer’s [13][11]. The loss of empathy and the presence of socially “embarrassing” behaviors can lead to profound isolation [13]. Seeking out FTD-specific support groups is essential. You are managing a complex neurological crisis, and you deserve support tailored to that reality [14].
Common questions in this guide
What medications are used to treat bvFTD behaviors?
Are antipsychotic medications safe for people with bvFTD?
What is the Tailored Activity Program (TAP) for dementia?
When should someone with bvFTD stop driving?
How can families protect their finances after a bvFTD diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are the potential side effects of using SSRIs like citalopram or trazodone for managing disinhibition?
- 2.If an antipsychotic is absolutely necessary, what specific extrapyramidal (movement-related) side effects should we watch for?
- 3.How can we access an occupational therapist trained in the Tailored Activity Program (TAP)?
- 4.What are the local legal requirements for reporting a dementia diagnosis to the DMV?
- 5.Can you provide a letter of medical necessity to help explain behavioral symptoms to legal or financial institutions if needed?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Transcriptomic and Network Meta-Analysis of Frontotemporal Dementias.
Bottero V, Alrafati F, Santiago JA, Potashkin JA
Frontiers in molecular neuroscience 2021; (14()):747798 doi:10.3389/fnmol.2021.747798.
PMID: 34720873 - 2
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs.
Logroscino G, Imbimbo BP, Lozupone M, et al.
Expert opinion on pharmacotherapy 2019; (20(9)):1091-1107 doi:10.1080/14656566.2019.1598377.
PMID: 31002267 - 3
Improving response inhibition systems in frontotemporal dementia with citalopram.
Hughes LE, Rittman T, Regenthal R, et al.
Brain : a journal of neurology 2015; (138(Pt 7)):1961-75 doi:10.1093/brain/awv133.
PMID: 26001387 - 4
Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.
Buoli M, Serati M, Caldiroli A, et al.
Journal of geriatric psychiatry and neurology 2017; (30(3)):162-169 doi:10.1177/0891988717700506.
PMID: 28351199 - 5
GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
Murley AG, Rouse MA, Jones PS, et al.
Brain : a journal of neurology 2020; (143(11)):3449-3462 doi:10.1093/brain/awaa305.
PMID: 33141154 - 6
The tailored activity program (TAP) to address behavioral disturbances in frontotemporal dementia: a feasibility and pilot study.
O'Connor CM, Clemson L, Brodaty H, et al.
Disability and rehabilitation 2019; (41(3)):299-310 doi:10.1080/09638288.2017.1387614.
PMID: 29034719 - 7
Tailored Activities to Reduce Neuropsychiatric Behaviors in Persons With Dementia: Case Report.
Marx KA, Scott JB, Piersol CV, Gitlin LN
The American journal of occupational therapy : official publication of the American Occupational Therapy Association 2019; (73(2)):7302205160p1-7302205160p9 doi:10.5014/ajot.2019.029546.
PMID: 30915977 - 8
Occupational Therapy Interventions for Dementia Caregivers: Scoping Review.
Martínez-Campos A, Compañ-Gabucio LM, Torres-Collado L, Garcia-de la Hera M
Healthcare (Basel, Switzerland) 2022; (10(9)) doi:10.3390/healthcare10091764.
PMID: 36141376 - 9
Behavioral Variant Frontotemporal Dementia and Social and Criminal Transgressions.
Mendez MF
The Journal of neuropsychiatry and clinical neurosciences 2022; (34(4)):328-340 doi:10.1176/appi.neuropsych.21080224.
PMID: 35306828 - 10
Trajectories of behavior and social cognition in behavioral variant frontotemporal dementia and primary psychiatric disorders: A call for better operationalization of socioemotional changes.
Fieldhouse JLP, van Engelen ME, Handgraaf D, et al.
European journal of neurology 2024; (31(12)):e16426 doi:10.1111/ene.16426.
PMID: 39171655 - 11
Psychological and social impacts of frontotemporal dementia on caregivers and family members - A systematic review.
Tan YL, Lo YKJ, Ho CSH
General hospital psychiatry 2024; (86()):33-49 doi:10.1016/j.genhosppsych.2023.11.011.
PMID: 38064912 - 12
Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.
Ganoza CA, Westenberger A, Paul JJ, et al.
Movement disorders : official journal of the Movement Disorder Society 2026; (41(4)):1020-1027 doi:10.1002/mds.70161.
PMID: 41439479 - 13
Neuropsychiatric Symptoms, Caregiver Burden and Distress in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
Lima-Silva TB, Bahia VS, Carvalho VA, et al.
Dementia and geriatric cognitive disorders 2015; (40(5-6)):268-75 doi:10.1159/000437351.
PMID: 26302667 - 14
The Impact of Caring on Psychological Wellbeing: A Qualitative Study in Carers of People Living With Behavioural-Variant Frontotemporal Dementia.
Ocampo IM, Todd J, Wei G, Kumfor F
Journal of geriatric psychiatry and neurology 2026; (39(4)):534-548 doi:10.1177/08919887251401262.
PMID: 41271195
This page provides educational information on managing bvFTD symptoms and daily life. Always consult a neurologist or healthcare provider before starting or changing medications or treatments.
Get notified when new evidence is published on Behavioral variant of frontotemporal dementia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.